Kelly R. Thornburg
Corporate Officer/Principal presso CHIMERIC THERAPEUTICS LIMITED
Profilo
Kelly R.
Thornburg is currently the Vice President & Head-Quality at Chimeric Therapeutics Ltd.
(Australia) since 2022.
Previously, Thornburg worked as an Executive Director-Quality at Amgen, Inc. and as the Head-US Commercial Manufacturing at Kite Pharma, Inc. Thornburg also served as the Senior Vice President-Operations at XBiotech, Inc. from 2015 to 2017.
Thornburg obtained an undergraduate degree from Rockhurst University.
Posizioni attive di Kelly R. Thornburg
| Società | Posizione | Inizio |
|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Corporate Officer/Principal | 03/02/2022 |
Precedenti posizioni note di Kelly R. Thornburg
| Società | Posizione | Fine |
|---|---|---|
| XBIOTECH INC. | Chief Operating Officer | 05/05/2017 |
| KITE PHARMA INC | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Formazione di Kelly R. Thornburg
| Rockhurst University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| XBIOTECH INC. | Health Technology |
| CHIMERIC THERAPEUTICS LIMITED | Health Technology |
| Aziende private | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Borsa valori
- Insiders
- Kelly R. Thornburg
